This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
This guide helps you decide which SP 500 fund is best for a Traditional IRA, covering cost, tracking, and suitability for retirement planning.
24,781 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Nuclear expansion plans are accelerating, and uranium ETFs are drawing fresh attention. A look at URA, URNM, URNJ, NL...
Retirees cling to a low-cost dividend ETF that advisors often push, yet most seniors can’t recall the ticker. This re...
When public interest meets private life, money follows. This article uncovers how decisions about paid interviews, pr...
Newly listed Roundhill DRAM ETF faces a volatile late-year backdrop as contract pricing and hyperscaler demand swing ...
When high-profile allegations surface, personal finances can feel the squeeze. This article breaks down the potential...
The Senate approved a $70 billion three-year funding package for ICE and Border Patrol, pushing the measure toward a ...
Direxion has unveiled SKHL, a 2X leveraged ETF tied to SK hynix, signaling a new foray into the memory-chip space. Th...
Powell Industries stock soars after a significant stake increase by a prominent fund, driving a 161% annual gain. Thi...
Jay-Z adds Paris Angeles stadium shows to his 30-year anniversary run signals more than a concert spree. This guide b...
Vanguard's Dividend Appreciation ETF (VIG) yields about 1.5% today, but behind that modest payout lies a 20-year stre...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...